Anticipating changes in the HER2 status of breast tumours with disease progression-towards better treatment decisions in the new era of HER2-low breast cancers.

Bergeron, Anthony; Bertaut, Aurélie; Beltjens, Françoise; Charon-Barra, Céline; Amet, Alix; Jankowski, Clémentine; Desmoulins, Isabelle; Ladoire, Sylvain; Arnould, Laurent

Bergeron, Anthony; Bertaut, Aurélie; Beltjens, Françoise; Charon-Barra, Céline; Amet, Alix; Jankowski, Clémentine; Desmoulins, Isabelle; Ladoire, Sylvain; Arnould, Laurent.

Bergeron A; Unit of Pathology, Department of Biology and Pathology of Tumours, Georges-François Leclerc [Cancer] Centre, 1 rue du Professeur Marion, 21000, Dijon, France. abergeron@cgfl.fr.
Bertaut A; Unit of Methodology and Biostatistics, Georges-François Leclerc [Cancer] Center, 1 rue du Professeur Marion, 21000, Dijon, France.
Beltjens F; Unit of Pathology, Department of Biology and Pathology of Tumours, Georges-François Leclerc [Cancer] Centre, 1 rue du Professeur Marion, 21000, Dijon, France.
Charon-Barra C; Unit of Pathology, Department of Biology and Pathology of Tumours, Georges-François Leclerc [Cancer] Centre, 1 rue du Professeur Marion, 21000, Dijon, France.
Amet A; Department of Surgery, Georges-François Leclerc [Cancer] Center, 1 rue du Professeur Marion, 21000, Dijon, France.
Jankowski C; Department of Surgery, Georges-François Leclerc [Cancer] Center, 1 rue du Professeur Marion, 21000, Dijon, France.
Desmoulins I; Department of Medical Oncology, Georges-François Leclerc [Cancer] Center, 1 rue du Professeur Marion, 21000, Dijon, France.
Ladoire S; Department of Medical Oncology, Georges-François Leclerc [Cancer] Center, 1 rue du Professeur Marion, 21000, Dijon, France.
Arnould L; INSERM U1231, 7 boulevard Jeanne d'Arc, 21000, Dijon, France.

Br J Cancer ; 129(1): 122-134, 2023 07.

Article en En | MEDLINE | ID: mdl-37120672

Asunto(s)

Neoplasias de la Mama; Receptor ErbB-2; Humanos; Femenino; Receptor ErbB-2/genética; Receptor ErbB-2/metabolismo; Neoplasias de la Mama/genética; Neoplasias de la Mama/terapia; Recurrencia Local de Neoplasia/genética; Recurrencia Local de Neoplasia/metabolismo; Receptores de Estrógenos/metabolismo; Receptores de Progesterona/metabolismo; Progresión de la Enfermedad; Biomarcadores de Tumor/genética; Biomarcadores de Tumor/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google